(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AMELUZ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

AMELUZ

ST13

US500000079079825

Class

5

Filing

79079825

Registration

3956761

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

51

Latest update

04/04/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

12/23/2009

Registration date

05/10/2011

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/02/2021

Last transaction

04/04/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

US

Examiner

AGOSTO, GISELLE MARIE

Law office

L20

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Biofrontera Inc.
Biofrontera Pharma GmbH
Biofrontera Pharma GmbH

Representatives

Jennifer Fraser Dykema Gossett PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of skin cancerthe elimination of tumors of the skin or the genital organswartsskin cells with neoplastic changes; pharmaceutical preparations for skin rejuvenation; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for wound healing; pharmaceutical preparations for the treatment of acne vulgaris; pharmaceutical preparations for anti-bacterial therapy; sanitary preparations for medical use; fungicidesherbicides; media for bacteriological cultures; bacteriological preparations for medical purposes; biological preparations for medical purposesskin disorders and skin cancers; biochemical preparations for medical purposesskin disorders and skin cancers; enzymes for medical purposes; ferments for pharmaceutical purposes; vaccines; nutritive substances for microorganisms for medical purposes; chemical preparations for sanitary purposes; chemical reagants for medical purposes; chemical preparations for sanitary use; medicines for the treatment of skin cancerthe elimination of tumors of the skin or the genital organswartsskin cells with neoplastic changes; medicines for skin rejuvenation; medicines for the treatment of psoriasis; medicines for wound healing; medicines for the treatment of acne vulgaris; medicines for anti-bacterial therapy; medicated ointments and gels for the treatment of skin disorders and skin cancers

Publications

History of USPTO decisions and trademark events.

51 publications found

DCPN

CHANGE OF OWNER RECEIVED FROM IB

04/02/2026

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

09/19/2022

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

08/12/2022

INPC

INVALIDATION PROCESSED

08/12/2022

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

06/02/2022

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

10/02/2021

71AG

REGISTERED-SEC.71 ACCEPTED

10/02/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/28/2021

ES71

TEAS SECTION 71 RECEIVED

05/06/2021

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

05/10/2020

RNWL

INTERNATIONAL REGISTRATION RENEWED

01/09/2020

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

06/10/2017

71AG

REGISTERED-SEC.71 ACCEPTED

06/10/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/05/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/12/2017

ES71

TEAS SECTION 71 RECEIVED

01/26/2017

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

05/10/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/28/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/27/2015

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/25/2013

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/04/2011

FIMP

FINAL DISPOSITION PROCESSED

10/04/2011

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/10/2011

R.PR

REGISTERED-PRINCIPAL REGISTER

05/10/2011

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/22/2011

PUBO

PUBLISHED FOR OPPOSITION

02/22/2011

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

02/19/2011

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/03/2011

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/03/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

01/15/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/14/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/11/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/10/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/10/2011

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/24/2010

GNRT

NON-FINAL ACTION E-MAILED

08/24/2010

CNRT

NON-FINAL ACTION WRITTEN

08/24/2010

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/20/2010

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/20/2010

ALIE

ASSIGNED TO LIE

08/20/2010

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/04/2010

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/08/2010

RFNT

REFUSAL PROCESSED BY IB

05/21/2010

MAFR

APPLICATION FILING RECEIPT MAILED

03/30/2010

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/29/2010

RFRR

REFUSAL PROCESSED BY MPU

03/29/2010

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/27/2010

CNRT

NON-FINAL ACTION WRITTEN

03/26/2010

DOCK

ASSIGNED TO EXAMINER

03/26/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/26/2010

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/25/2010

Continuous trademark protection

Get notified about every new filing that threatens AMELUZ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.